Literature DB >> 24567067

Investigating the role of transferrin in the distribution of iron, manganese, copper, and zinc.

Carolina Herrera1, Michael A Pettiglio, Thomas B Bartnikas.   

Abstract

The essential role of transferrin in mammalian iron metabolism is firmly established. Integral to our understanding of transferrin, studies in hypotransferrinemic mice, a model of inherited transferrin deficiency, have demonstrated that transferrin is essential for iron delivery for erythropoiesis and in the regulation of expression of hepcidin, a hormone that inhibits macrophage and enterocyte iron efflux. Here we investigate a potential role for transferrin in the distribution of three other physiologic metals, manganese, copper, and zinc. We first assessed metal content in transferrin-rich fractions of wild-type mouse sera and demonstrate that although both iron and manganese cofractionated predominantly with transferrin, the absolute levels of manganese are several orders of magnitude lower than those of iron. We next measured metal content in multiple tissues in wild-type and hypotransferrinemic mice of various ages. Tissue metal imbalances were severe for iron and minimal to moderate for some metals in some tissues in hypotransferrinemic mice. Metal levels measured in a transferrin-replete yet hepcidin-deficient and iron-loaded mouse strain suggested that the observed imbalances in tissue copper, zinc, and manganese levels were not all specific to hypotransferrinemic mice or caused directly by transferrin deficiency. Overall, our results suggest that transferrin does not have a primary role in the distribution of manganese, copper, or zinc to tissues and that the abnormalities observed in tissue manganese levels are not attributable to a direct role for transferrin in manganese metabolism but rather are attributable to an indirect effect of transferrin deficiency on hepcidin expression and/or iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24567067      PMCID: PMC4119503          DOI: 10.1007/s00775-014-1118-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  32 in total

Review 1.  Known and potential roles of transferrin in iron biology.

Authors:  Thomas Benedict Bartnikas
Journal:  Biometals       Date:  2012-08       Impact factor: 2.949

2.  Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.

Authors:  Marialuisa Quadri; Antonio Federico; Tianna Zhao; Guido J Breedveld; Carla Battisti; Cathérine Delnooz; Lies-Anne Severijnen; Lara Di Toro Mammarella; Andrea Mignarri; Lucia Monti; Antioco Sanna; Peng Lu; Francesca Punzo; Giovanni Cossu; Rob Willemsen; Fabrizio Rasi; Ben A Oostra; Bart P van de Warrenburg; Vincenzo Bonifati
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

3.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.

Authors:  Karin Tuschl; Peter T Clayton; Sidney M Gospe; Shamshad Gulab; Shahnaz Ibrahim; Pratibha Singhi; Roosy Aulakh; Reinaldo T Ribeiro; Orlando G Barsottini; Maha S Zaki; Maria Luz Del Rosario; Sarah Dyack; Victoria Price; Andrea Rideout; Kevin Gordon; Ron A Wevers; W K Kling Chong; Philippa B Mills
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

4.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

Review 5.  Hepcidin and disorders of iron metabolism.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 6.  The binding and transport of alternative metals by transferrin.

Authors:  John B Vincent; Sharifa Love
Journal:  Biochim Biophys Acta       Date:  2011-07-18

7.  Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice.

Authors:  Thomas B Bartnikas; Nancy C Andrews; Mark D Fleming
Journal:  Blood       Date:  2010-10-18       Impact factor: 22.113

8.  The iron transporter ferroportin can also function as a manganese exporter.

Authors:  Michael S Madejczyk; Nazzareno Ballatori
Journal:  Biochim Biophys Acta       Date:  2011-12-08

9.  Absorption of manganese and iron in a mouse model of hemochromatosis.

Authors:  Jonghan Kim; Peter D Buckett; Marianne Wessling-Resnick
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.

Authors:  Maria Stamelou; Karin Tuschl; W K Chong; Andrew K Burroughs; Philippa B Mills; Kailash P Bhatia; Peter T Clayton
Journal:  Mov Disord       Date:  2012-08-23       Impact factor: 10.338

View more
  16 in total

1.  Pharmacokinetic evaluation of the equivalency of gavage, dietary, and drinking water exposure to manganese in F344 rats.

Authors:  Melanie L Foster; Thomas B Bartnikas; Laura C Johnson; Carolina Herrera; Michael A Pettiglio; Athena M Keene; Michael D Taylor; David C Dorman
Journal:  Toxicol Sci       Date:  2015-02-26       Impact factor: 4.849

Review 2.  The use of hypotransferrinemic mice in studies of iron biology.

Authors:  Julia T Bu; Thomas B Bartnikas
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

Review 3.  Influence of iron metabolism on manganese transport and toxicity.

Authors:  Qi Ye; Jo Eun Park; Kuljeet Gugnani; Swati Betharia; Alejandro Pino-Figueroa; Jonghan Kim
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

4.  Iron incorporation into MnSOD A (bacterial Mn-dependent superoxide dismutase) leads to the formation of a peroxidase/catalase implicated in oxidative damage to bacteria.

Authors:  Douglas Ganini; Robert M Petrovich; Lori L Edwards; Ronald P Mason
Journal:  Biochim Biophys Acta       Date:  2015-05-09

5.  A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.

Authors:  Lisa G Riley; Mark J Cowley; Velimir Gayevskiy; Tony Roscioli; David R Thorburn; Kristina Prelog; Melanie Bahlo; Carolyn M Sue; Shanti Balasubramaniam; John Christodoulou
Journal:  J Inherit Metab Dis       Date:  2016-12-19       Impact factor: 4.982

6.  SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.

Authors:  Julien H Park; Max Hogrebe; Marianne Grüneberg; Ingrid DuChesne; Ava L von der Heiden; Janine Reunert; Karl P Schlingmann; Kym M Boycott; Chandree L Beaulieu; Aziz A Mhanni; A Micheil Innes; Konstanze Hörtnagel; Saskia Biskup; Eva M Gleixner; Gerhard Kurlemann; Barbara Fiedler; Heymut Omran; Frank Rutsch; Yoshinao Wada; Konstantinos Tsiakas; René Santer; Daniel W Nebert; Stephan Rust; Thorsten Marquardt
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

7.  Variance components of short-term biomarkers of manganese exposure in an inception cohort of welding trainees.

Authors:  Marissa G Baker; Christopher D Simpson; Lianne Sheppard; Bert Stover; Jackie Morton; John Cocker; Noah Seixas
Journal:  J Trace Elem Med Biol       Date:  2014-05-23       Impact factor: 3.849

8.  Impact of low- and high-molecular-mass components of human serum on NAMI-A binding to transferrin.

Authors:  K Śpiewak; M Brindell
Journal:  J Biol Inorg Chem       Date:  2015-03-20       Impact factor: 3.358

Review 9.  Iron, hepcidin, and the metal connection.

Authors:  Olivier Loréal; Thibault Cavey; Edouard Bardou-Jacquet; Pascal Guggenbuhl; Martine Ropert; Pierre Brissot
Journal:  Front Pharmacol       Date:  2014-06-04       Impact factor: 5.810

Review 10.  The Potential Roles of Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier in Maintaining Brain Manganese Homeostasis.

Authors:  Shannon Morgan McCabe; Ningning Zhao
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.